DPP4 Inhibitors for Target Therapy Resistance in Renal Cell Carcinoma

News

September 20, 2023
PRESS RELEASE: On September 15, 2023, a new editorial was published in Oncotarget, entitled, “Potential repurposing of DPP4 inhibitors for target therapy resistance in renal cell carcinoma.” continue reading »

Validation of a Comprehensive Genomic Profiling Assay: NeXT Dx™

News

August 30, 2023
PRESS RELEASE: On August 30, 2023, a new research paper was published in Oncotarget, entitled, “Analytic validation of NeXT Dx™, a comprehensive genomic profiling assay.” continue reading »

A Macrophage is a Macrophage is a Macrophage—in Metastasis

News

August 23, 2023
PRESS RELEASE: On June 6, 2023, a new editorial was published in Oncotarget, entitled, “A macrophage is a macrophage is a macrophage—in metastasis.” continue reading »

Whole-Genome Doubling and Aneuploidy in Human Cancer

Oncotarget

August 10, 2023
In a new editorial paper, researchers from Tel Aviv University discuss a recent study exploring how whole-genome doubling shapes the aneuploidy landscape of human cancers. continue reading »

Navigating the Frailty Factor in Atrial Fibrillation Management

Aging

August 3, 2023
In a new editorial, researchers discuss the impact of frailty on clinical decision-making in managing patients with atrial fibrillation and the prescription of oral anticoagulants. continue reading »